Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000395836 | SCV000336918 | uncertain significance | not provided | 2015-12-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000395836 | SCV001074470 | benign | not provided | 2023-06-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002518921 | SCV003706807 | uncertain significance | Inborn genetic diseases | 2022-05-06 | criteria provided, single submitter | clinical testing | The c.1340C>T (p.T447I) alteration is located in exon 9 (coding exon 9) of the TNFRSF11A gene. This alteration results from a C to T substitution at nucleotide position 1340, causing the threonine (T) at amino acid position 447 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |